Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
SLAMF7 and SLAMF8 receptors shape human plasmacytoid dendritic cell responses to intracellular bacteria
Joaquín Miguel Pellegrini, … , Sylvie Mémet, Jean-Pierre Gorvel
Joaquín Miguel Pellegrini, … , Sylvie Mémet, Jean-Pierre Gorvel
Published April 15, 2025
Citation Information: J Clin Invest. 2025;135(8):e182467. https://doi.org/10.1172/JCI182467.
View: Text | PDF
Research Article Immunology Infectious disease Microbiology

SLAMF7 and SLAMF8 receptors shape human plasmacytoid dendritic cell responses to intracellular bacteria

  • Text
  • PDF
Abstract

Plasmacytoid dendritic cells (pDCs), professional type I IFN–producing cells, have been implicated in host responses against bacterial infections. However, their role in host defense is debated, and the operating molecular mechanisms are unknown. Certain signaling lymphocyte activation molecule family (SLAMF) members act as microbial sensors and modulate immune functions in response to infection. Here, human blood transcriptomic analyses reveal the involvement of SLAMF7 and SLAMF8 in many infectious diseases, with elevated levels associated with type I IFN responses in salmonellosis and brucellosis patients. We further identify SLAMF7 and SLAMF8 as key regulators of human pDC function. They activate pDC maturation and cytokine production during infection with bacteria that induce acute (Salmonella) or chronic (Brucella) inflammation. SLAMF7 and SLAMF8 signal through NF-κB, IRF7, and STAT-1, and limit mitochondrial ROS accumulation upon Salmonella infection. Remarkably, this SLAMF7/8-dependent control of mitochondrial ROS levels favors bacterial persistence and NF-κB activation. Overall, our results unravel essential shared multifaceted roles of SLAMF7 and SLAMF8 in finely tuning human pDC responses to intracellular bacterial infections with potential for future diagnostic and therapeutic applications.

Authors

Joaquín Miguel Pellegrini, Anne Keriel, Laurent Gorvel, Sean Hanniffy, Vilma Arce-Gorvel, Mile Bosilkovski, Javier Solera, Stéphane Méresse, Sylvie Mémet, Jean-Pierre Gorvel

×

Figure 1

Blood transcriptomic signatures reveal the participation of SLAMF receptors during infection, and of SLAMF7 and SLAMF8 in brucellosis.

Options: View larger image (or click on image) Download as PowerPoint
Blood transcriptomic signatures reveal the participation of SLAMF recept...
(A) Heatmap from blood transcriptomics data showing the differential expression of SLAMF receptors between healthy donor (HD) individuals and patients suffering from flu (GSE100160), COVID-19 (GSE152075), malaria (GSE116149), Lyme disease (GSE145974), tuberculosis (GSE19491), staphylococcal infection (GSE100165), streptococcal pharyngitis (GSE158163), brucellosis (GSE69597), and salmonellosis (GSE113866). –Log10 P values are shown with intensity of the color representing the degree of variation from HDs. (B and C) RNA-Seq transcriptomic profiling obtained from whole-blood samples from HD controls or primary brucellosis patients in acute, acute relapse, or chronic phase of infection. (B) The median expression of SLAMF7 and SLAMF8 normalized counts is shown. X axis: HD controls, n = 36 (gray); brucellosis patients, acute, n = 54 (purple), acute with relapse, n = 6 (pink), chronic, n = 12 (orange). Y axis: log2 residual gene expression counts. Multiple-comparison Kruskal-Wallis test followed by post hoc Dunn’s test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. (C–E) “SLAMF” refers to SLAMF7 and SLAMF8. (C) Heatmap showing type I IFN module gene expression from whole-blood RNA-Seq data from SLAMFhi (n = 21, dark red) and SLAMFlo (n = 22, turquoise) brucellosis patients. (D) Orthogonal partial least squares discriminant analysis (OPLS-DA) loading plots of cytokines and chemokines measured in serum, harvested at first visit, from SLAMFhi (n = 21, dark red) and SLAMFlo (n = 22, turquoise) brucellosis patients. (E) Univariate analysis of selected cytokine concentration (pg/mL) in serum of SLAMFhi (pink) and SLAMFlo (cyan) brucellosis patients. TNF-α and IFN-α, SLAMFhi (n = 9) and SLAMFlo (n = 8); IL-6, SLAMFhi (n = 16) and SLAMFlo (n = 18). Significant differences are shown (Mann-Whitney test), *P < 0.05.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts